Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients.
Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis.
Cuprizone neurotoxicity in the rat: morphologic observations.
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
Breastfeeding is not related to postpartum relapses in multiple sclerosis.
Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone.
Biogen Idec's TECFIDERA™ (dimethyl fumarate) approved in US as a first-line oral treatment for multiple sclerosis
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.
B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients.
“Human Medicines” page
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.
Rituximab does not reset defective early B cell tolerance checkpoints.
Biogen Data at 2016 AAN Annual Meeting Highlight Its Expansive Portfolio of MS Therapies That Meets Diverse Needs of Patients
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages.
Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome.
T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion.
Checklist for reporting and reviewing studies of experimental animal models of multiple sclerosis and related disorders.

Pages